Cargando…

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres

PURPOSE: Glioblastoma (GBM) is the most aggressive type of brain tumor and has poor survival outcomes, even after a combination of surgery, radiotherapy, and chemotherapy. Temozolomide is the only agent that has been shown to be effective against GBM, suggesting that combination of temozolomide with...

Descripción completa

Detalles Bibliográficos
Autores principales:	Oh, Hyeong-Cheol, Shim, Jin-Kyoung, Park, Junseong, Lee, Ji-Hyun, Choi, Ran Joo, Kim, Nam Hee, Kim, Hyun Sil, Moon, Ju Hyung, Kim, Eui Hyun, Chang, Jong Hee, Yook, Jong In, Kang, Seok-Gu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Original Article – Cancer Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7519913/ https://www.ncbi.nlm.nih.gov/pubmed/32712753 http://dx.doi.org/10.1007/s00432-020-03330-7

Ejemplares similares

Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
por: Shim, Jin-Kyoung, et al.
Publicado: (2022)

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres
por: Park, Hun Ho, et al.
Publicado: (2021)

Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)
por: Choi, Junjeong, et al.
Publicado: (2016)

Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program
por: Park, Junseong, et al.
Publicado: (2023)

A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1
por: Shim, Jin-Kyoung, et al.
Publicado: (2022)

Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
por: Yoon, Seon-Jin, et al.
Publicado: (2020)

Success of tumorsphere isolation from WHO grade IV gliomas does not correlate with the weight of fresh tumor specimens: an immunohistochemical characterization of tumorsphere differentiation
por: Sung, Kyoung Su, et al.
Publicado: (2016)

Metformin and Niclosamide Synergistically Suppress Wnt and YAP in APC-Mutated Colorectal Cancer
por: Kang, Hee Eun, et al.
Publicado: (2021)

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
por: Roh, Tae Hoon, et al.
Publicado: (2020)

Anti-helminthic niclosamide inhibits Ras-driven oncogenic transformation via activation of GSK-3
por: Ahn, Sung Yong, et al.
Publicado: (2017)

Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor
por: Park, Junseong, et al.
Publicado: (2023)

Niclosamide is a potential therapeutic for familial adenomatosis polyposis by disrupting Axin-GSK3 interaction
por: Ahn, Sung Yong, et al.
Publicado: (2017)

Glioblastoma Cellular Origin and the Firework Pattern of Cancer Genesis from the Subventricular Zone
por: Yoon, Seon-Jin, et al.
Publicado: (2020)

Ambient carbon monoxide exposure and elevated risk of mortality in the glioblastoma patients: A double‐cohort retrospective observational study
por: Yoon, Seon‐Jin, et al.
Publicado: (2020)

Niclosamide and Pyrvinium Are Both Potential Therapeutics for Osteosarcoma, Inhibiting Wnt–Axin2–Snail Cascade
por: Yi, Young, et al.
Publicado: (2021)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

Novel cancer stem cell marker MVP enhances temozolomide-resistance in glioblastoma
por: Noh, Kum Hee, et al.
Publicado: (2021)

Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
por: Kim, Hee Yeon, et al.
Publicado: (2019)

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
por: Park, Junseong, et al.
Publicado: (2019)

The Pentose Phosphate Pathway as a Potential Target for Cancer Therapy
por: Cho, Eunae Sandra, et al.
Publicado: (2018)

Stereotactic biopsy for adult brainstem lesions: A surgical approach and its diagnostic value according to the 2016 World Health Organization Classification
por: Jung, In‐Ho, et al.
Publicado: (2021)

Prognostic Value of Glioma Cancer Stem Cell Isolation in Survival of Primary Glioblastoma Patients
por: Kong, Byung Ho, et al.
Publicado: (2014)

Tumor Mesenchymal Stem-Like Cell as a Prognostic Marker in Primary Glioblastoma
por: Yoon, Seon-Jin, et al.
Publicado: (2016)

Exploring the chemical space of protein–protein interaction inhibitors through machine learning
por: Choi, Jiwon, et al.
Publicado: (2021)

Assessing Spatial Distribution of Multicellular Self-Assembly Enables the Prediction of Phenotypic Heterogeneity in Glioblastoma
por: Cha, Junghwa, et al.
Publicado: (2022)

One-Year Outcome of Multiple Blood–Brain Barrier Disruptions With Temozolomide for the Treatment of Glioblastoma
por: Park, So Hee, et al.
Publicado: (2020)

Ethnic delineation of primary glioblastoma genome
por: Koo, Harim, et al.
Publicado: (2020)

Investigation of niclosamide as a repurposing agent for skeletal muscle atrophy
por: Kim, Hyun-Jun, et al.
Publicado: (2021)

Breast Cancer Subtypes Underlying EMT-Mediated Catabolic Metabolism
por: Cho, Eunae Sandra, et al.
Publicado: (2020)

GEN-13 FIREWORK PATTERN OF CANCER GENESIS FOR GLIOBLASTOMA, IDH-WILDTYPE
por: Yoon, Seon-Jin, et al.
Publicado: (2019)

Correction: Secretome analysis of patient-derived GBM tumorspheres identifies midkine as a potent therapeutic target
por: Han, Suji, et al.
Publicado: (2020)

Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres
por: Fanfone, Deborah, et al.
Publicado: (2020)

Temozolomide during and after Radiotherapy for Newly Diagnosed Glioblastomas : A Prospective Multicenter Study of Korean Patients
por: Joo, Jin-Deok, et al.
Publicado: (2012)

Phase II trial of upfront bevacizumab and temozolomide for unresectable or multifocal glioblastoma
por: Lou, Emil, et al.
Publicado: (2013)

Impact of Including Peritumoral Edema in Radiotherapy Target Volume on Patterns of Failure in Glioblastoma following Temozolomide-based Chemoradiotherapy
por: Choi, Seo Hee, et al.
Publicado: (2017)

Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
por: Mukthavaram, Rajesh, et al.
Publicado: (2015)

Bone morphogenetic protein-7 attenuates pancreatic damage under diabetic conditions and prevents progression to diabetic nephropathy via inhibition of ferroptosis
por: Song, Sang Hyun, et al.
Publicado: (2023)

Glycogen Synthase Kinase-3 Interaction Domain Enhances Phosphorylation of SARS-CoV-2 Nucleocapsid Protein
por: Yun, Jun Seop, et al.
Publicado: (2022)

Micellized Protein Transduction Domain-Bone Morphogenetic Protein-7 Efficiently Blocks Renal Fibrosis Via Inhibition of Transforming Growth Factor-Beta–Mediated Epithelial–Mesenchymal Transition
por: Kim, Seonghun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_qatg4t7f5v35o1el1lbidaui5r